v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 9,707 $ 11,536
Selling, general and administrative 6,417 7,308
Total operating expenses 16,124 18,844
Other income (expense):    
Interest income 1,442 2,231
Other expense (15) 0
Total other income 1,427 2,231
Net loss $ (14,697) $ (16,613)
Net loss per share attributable to common stockholders, basic (in dollars per share) $ (0.12) $ (0.13)
Net loss per share attributable to common stockholders, diluted (in dollars per share) $ (0.12) $ (0.13)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares) 126,634,782 126,144,240
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares) 126,634,782 126,144,240